The AHA and Federation of American Hospitals “strongly believe that any public policy solution to resolve surprise bills must protect patients by prohibiting balance billing and by limiting patients’ cost-sharing to an in-network amount,” the organizations today told members of Congress. “We appreciate that this is a high-priority issue for Congress, as it is for us, and we intend to provide more specific feedback to policymakers early in the new Congress,” the organizations said in a letter to Congressional leadership, members of the Bipartisan Senate Working Group on Health Care Price Transparency and other interested members of Congress. AHA and FAH said they are evaluating, for example, how to protect the broadest range of patients, including those in self-insured plans; how cost-sharing should be determined for out-of-network care so that patients have certainty about their financial obligations; the role of network adequacy requirements and enforcement in ensuring patients have sufficient access to in-network care; and whether policy interventions are needed to determine fair provider payment.

Related News Articles

News
The AHA April 29 urged majority and minority leaders in both the Senate and House to not make disruptive policy changes to Medicaid and other coverage options…
Perspective
Public
One year ago, a nurse at Children’s Hospital Colorado went above and beyond in a way that a very young patient and her family will never forget. Kayla…
Headline
The AHA voiced support for the Securing Access to Care for Seniors in Critical Condition Act (H.R.1924), legislation that would provide reimbursement for long-…
Headline
Twelve House Republicans April 14 sent a letter to House leadership voicing their opposition to potential Medicaid cuts. The lawmakers said they support “…
Headline
The White House April 15 released an executive order directing federal agencies to undertake a broad range of tasks aimed at reducing the costs of prescription…
Headline
The Department of Commerce yesterday released notices announcing national security investigations on imports of pharmaceuticals, pharmaceutical ingredients and…